Checkpoint Therapeutics Stock (NASDAQ: CKPT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 381.14K |
Day Range | - - - |
52 Wk Range | 1.30 - 3.62 |
Market Cap | $100.91M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 69 |
Short Interest | 11.06% |
Days to Cover | 10.2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Checkpoint Therapeutics (NASDAQ:CKPT) through any online brokerage.
Other companies in Checkpoint Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), Armata Pharmaceuticals (AMEX:ARMP) and Vistagen Therapeutics (NASDAQ:VTGN).
There is no analysis for Checkpoint Therapeutics.
Checkpoint Therapeutics has a consensus price target of $30.33.
The stock price for Checkpoint Therapeutics (NASDAQ: CKPT) is $2.6499 last updated July 23, 2024 at 7:29 PM EDT.
There are no upcoming dividends for Checkpoint Therapeutics.
Checkpoint Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Checkpoint Therapeutics.
Checkpoint Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.